
Work Here?
Company Does Not Provide H1B Sponsorship
Xyme designs AI-generated enzymes, called xymes, that catalyze chemical reactions and expand the toolkit of synthetic chemistry. It combines artificial intelligence, quantum chemistry, and experimental data to create enzymes tailored to drive specific reactions. The product is a designed enzyme, produced in the lab, validated through experiments, and guided by AI-driven predictions of structure and activity to enable catalysis across a wide range of chemical processes. Xyme differentiates itself by integrating AI, quantum chemistry, and real-world experimental validation to design enzymes capable of catalyzing many reactions, positioning two UK locations (Oxford and Manchester) as innovation hubs. The company aims to address large societal challenges by advancing synthetic chemistry, growing its team with AI and biotech experts, and building a scalable platform to design and deploy new enzymes for diverse industries.
Industries
Data & Analytics
Industrial & Manufacturing
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Oxford, United Kingdom
Founded
2024
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Conference Attendance Budget
Flexible Work Hours
Oxford scientist recognised for AI molecular discovery work. Ed Pyzer-Knapp, co-founder and chief scientific officer of Oxford-based AI company Xyme (Image: Supplied) A leading scientific mind is being celebrated for his groundbreaking work. Ed Pyzer-Knapp, co-founder and chief scientific officer of Oxford-based AI company Xyme, has been awarded the Royal Society of Chemistry's (RSC) Interdisciplinary Prize. Dr Pyzer-Knapp received the honour for uniting chemistry, physics and AI into a new approach for molecular discovery. He said: "I'm honoured to receive the RSC Interdisciplinary Prize. "The previous recipients are a who's who of interdisciplinary chemistry; it is a privilege to be among them. "The award comes at the right moment. "The work of the last decade is beginning to bear fruit and I know at Xyme, I'm exactly where I need to be to make the most of it." At Xyme, Dr Pyzer-Knapp leads the development of morphogenic AI, a first-of-its-kind AI able to computationally generate purpose-built molecular machines designed to perform specific chemical reactions. Andrew Hopkins, CEO and co-founder of Xyme, praised his colleague for his vision and technical skill. He said: "Ed is one of only a handful of scientists in the world who can move fluently and expertly across quantum physics, chemistry and AI. "That breadth is what makes genuine innovation possible - and this is what teaching AI physics looks like in practice. "Many congratulations to him." The RSC Interdisciplinary Prize has been awarded annually since 1986 to researchers whose work advances knowledge across disciplinary boundaries. Dr Pyzer-Knapp is one of the youngest recipients in the award's history.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Industrial & Manufacturing
AI & Machine Learning
Biotechnology
Company Size
11-50
Company Stage
N/A
Total Funding
N/A
Headquarters
Oxford, United Kingdom
Founded
2024
Find jobs on Simplify and start your career today